Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mann

Showing results (851-860 of 909) with videos related to

Pageof 91
Sort By:
Journal of Cardiac Failure|April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI TrialKarola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Circulation. Heart Failure|April 16, 2013
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trialsArthur M Feldman, Douglas L Mann, Lilin She, et al.
Circulation. Heart Failure|November 15, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United StatesMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
The Annals of Thoracic Surgery|November 17, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summaryMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
Circulation. Heart Failure|November 15, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summaryMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
The Annals of Thoracic Surgery|November 17, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United StatesMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
Journal of the American College of Cardiology|February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMIDouglas L Mann, Johny Nicolas, Brian Claggett, et al.
JACC. Heart Failure|July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE TrialDouglas L Mann, Stephen J Greene, Michael M Givertz, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Circulation. Heart Failure|January 28, 2026
Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart FailureMahesh K Vidula, Leon J Schurgers, Lei Zhao, et al.
Pageof 91

Showing results (851-860 of 909) with videos related to

Sort By:
Pageof 91
Journal of Cardiac Failure|April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI TrialKarola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Circulation. Heart Failure|April 16, 2013
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trialsArthur M Feldman, Douglas L Mann, Lilin She, et al.
Circulation. Heart Failure|November 15, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United StatesMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
The Annals of Thoracic Surgery|November 17, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summaryMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
Circulation. Heart Failure|November 15, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summaryMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
The Annals of Thoracic Surgery|November 17, 2012
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United StatesMichael A Acker, Francis D Pagani, Wendy Gattis Stough, et al.
Journal of the American College of Cardiology|February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMIDouglas L Mann, Johny Nicolas, Brian Claggett, et al.
JACC. Heart Failure|July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE TrialDouglas L Mann, Stephen J Greene, Michael M Givertz, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Circulation. Heart Failure|January 28, 2026
Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart FailureMahesh K Vidula, Leon J Schurgers, Lei Zhao, et al.
Pageof 91